<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
pmid: 13154603
PHENYLBUTAZONE (3, 5-dioxo-l, 2–diphenyl4-n-butyl-pyrazolidin sodium) is a pyrazolon derivative with anti-inflammatory and analgesic properties.1 Its formula is as follows: Success with this drug in the treatment of gout has previously been reported by Gutman and Yu,2 by Kuzell et al.,3 , 4 and by Steinbrocker and his associates.5 In the past year we have observed its effects in 26 male adult patients with gouty arthritis, of whom 10 had acute arthritis and 16 chronic joint disease. Methods Patients with acute arthritis were seen on an outpatient basis; patients with chronic diseases were hospitalized, when indicated, on the medical wards at the Veterans . . .
Analgesics, Gout, Phenylbutazone
Analgesics, Gout, Phenylbutazone
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 20 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |